Beslagsmed Anders Yde ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 3.5% 3.6% 2.5%  
Credit score (0-100)  0 0 51 52 62  
Credit rating  N/A N/A BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 1,429 795 815  
EBITDA  0.0 0.0 597 157 148  
EBIT  0.0 0.0 590 148 106  
Pre-tax profit (PTP)  0.0 0.0 584.6 142.9 105.8  
Net earnings  0.0 0.0 456.0 116.2 83.3  
Pre-tax profit without non-rec. items  0.0 0.0 585 143 106  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  0.0 0.0 21.2 179 241  
Shareholders equity total  0.0 0.0 496 512 495  
Interest-bearing liabilities  0.0 0.0 7.8 54.0 8.3  
Balance sheet total (assets)  0.0 0.0 770 700 721  

Net Debt  0.0 0.0 -642 -322 -363  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 1,429 795 815  
Gross profit growth  0.0% 0.0% 0.0% -44.4% 2.6%  
Employees  0 0 0 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 770 700 721  
Balance sheet change%  0.0% 0.0% 0.0% -9.1% 3.0%  
Added value  0.0 0.0 597.4 155.5 148.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 14 149 20  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 41.3% 18.6% 13.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 76.6% 20.1% 14.9%  
ROI %  0.0% 0.0% 116.0% 27.2% 19.4%  
ROE %  0.0% 0.0% 91.9% 23.0% 16.5%  

Solidity 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  0.0% 0.0% 64.4% 73.2% 68.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -107.5% -204.8% -244.4%  
Gearing %  0.0% 0.0% 1.6% 10.6% 1.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 130.5% 15.5% 0.2%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.0 0.0 2.6 2.8 2.2  
Current Ratio  0.0 0.0 2.8 3.0 2.2  
Cash and cash equivalent  0.0 0.0 650.0 375.6 370.9  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 479.4 344.9 261.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 155 148  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 157 148  
EBIT / employee  0 0 0 148 106  
Net earnings / employee  0 0 0 116 83